Freedman S F, McCormick K, Cox T A
Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, USA.
J AAPOS. 1999 Apr;3(2):117-24. doi: 10.1016/s1091-8531(99)70082-0.
The purpose of this study was to evaluate mitomycin C-augmented trabeculectomy combined with postoperative subconjunctival 5-fluorouracil and laser suture lysis in the treatment of refractory pediatric glaucoma.
Twenty-one consecutive cases (17 patients) with refractory pediatric glaucoma treated with mitomycin C trabeculectomy (0.4 mg/mL for 3 to 5 minutes) and postoperative 5-fluorouracil, laser suture lysis, or both were retrospectively reviewed. Success was defined as intraocular pressure between 4 and 16 mm Hg without further glaucoma surgery or devastating complication.
The median age of the study population was 2.6 years (range, 0.05 to 16 years). The overall success rate was 52.4%, with a median follow-up of 23 months for successful cases. Success rates for patients older than 1 year of age versus those younger than 1 year of age at surgery were 73% and 30%, respectively. Success rates for phakic versus aphakic eyes were 64% and 29%, respectively. Age and lens status, taken together, were significant predictors of outcome (P = .013). Reasons for failure in this study were uncontrolled intraocular pressure (8 cases), persistent wound leak (1 case), and endophthalmitis (1 case); the latter 2 cases required bleb excision. Other complications encountered included chorioretinal detachment, shallow anterior chamber, 5-fluorouracil toxicity, and cataract formation. No irreversible visual deficits could be attributed to the trabeculectomy procedure or subsequent complications in any of these cases.
Mitomycin C-augmented trabeculectomy combined with postoperative suture lysis and 5-fluorouracil is a viable option for older phakic children with refractory glaucoma. This procedure has a lower success rate in infants and in aphakic eyes. Both early and late postoperative complications are common, and diligent lifelong long-term follow-up is needed to detect bleb leaks and infection. The addition of postoperative suture lysis and 5-fluorouracil to mitomycin C-augmented trabeculectomy did not provide any convincing improvement in the success of this procedure in pediatric patients with refractory glaucoma and may have increased the complication rate.
本研究旨在评估丝裂霉素C增强小梁切除术联合术后结膜下注射5-氟尿嘧啶及激光缝线松解术治疗难治性儿童青光眼的疗效。
回顾性分析连续21例(17例患者)接受丝裂霉素C小梁切除术(0.4 mg/mL,持续3至5分钟)及术后5-氟尿嘧啶、激光缝线松解术或两者联合治疗的难治性儿童青光眼病例。成功定义为眼压在4至16 mmHg之间,无需进一步青光眼手术或发生严重并发症。
研究人群的中位年龄为2.6岁(范围0.05至16岁)。总体成功率为52.4%,成功病例的中位随访时间为23个月。手术时年龄大于1岁与小于1岁的患者成功率分别为73%和30%。有晶状体眼与无晶状体眼的成功率分别为64%和29%。年龄和晶状体状态综合起来是结果的显著预测因素(P = 0.013)。本研究中失败的原因包括眼压控制不佳(8例)、持续性伤口渗漏(1例)和眼内炎(1例);后2例需要切除滤过泡。其他遇到的并发症包括脉络膜视网膜脱离、前房变浅、5-氟尿嘧啶毒性反应和白内障形成。在任何这些病例中,均未发现不可逆的视力缺陷可归因于小梁切除术或随后的并发症。
丝裂霉素C增强小梁切除术联合术后缝线松解术及5-氟尿嘧啶是治疗难治性青光眼的大龄有晶状体儿童的可行选择。该手术在婴儿和无晶状体眼中成功率较低。术后早期和晚期并发症均很常见,需要进行终身长期密切随访以检测滤过泡渗漏和感染。在丝裂霉素C增强小梁切除术中加用术后缝线松解术和5-氟尿嘧啶,对于难治性青光眼儿童患者,该手术的成功率并未得到任何令人信服的提高,且可能增加了并发症发生率。